You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Identification and Characterization of an Alternative Cytotoxic T Lymphocyte-Associated Protein 4 Binding Molecule on B Cells
Masaaki Murakami, Yohko Takahashi, Yasuhiro Isashi, Shigeyuki Kon, Wen-Yi Jia, Manabu Inobe, Ryo Abe and Toshimitsu Uede
Proceedings of the National Academy of Sciences of the United States of America
Vol. 93, No. 15 (Jul. 23, 1996), pp. 7838-7842
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/40123
Page Count: 5
You can always find the topics here!Topics: T lymphocytes, Molecules, B lymphocytes, CHO cells, Spleen cells, Complementary DNA, Antigen presenting cells, Signals, Spleen, Cultured cells
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
To determine whether alternative cytotoxic T lymphocyte-associated protein 4 (CTLA4) binding proteins exist on B cells, we constructed (i) mCTLA4hIgG consisting of the extracellular region of a mouse CTLA4 molecule and the Fc portion of a human IgG1 molecule and (ii) PYAAhIgG, a mutant mCTLA4hIgG, having two amino acid substitutions on the conserved MYPPPY motif in the complementarity-determining region 3-like region and lacking detectable binding to both B7-1 and B7-2 molecules. Using these fusion proteins (mCTLA4hIgG and PYAAhIgG), we demonstrated that a mouse immature B-cell line, WEHI231 cells, expressed alternative CTLA4 binding molecules (ACBMs) that were distinct from both B7-1 and B7-2. ACBMs were 130-kDa disulfide-linked proteins. More importantly, ACBMs were able to provide costimulatory signal for T-cell proliferation in the presence of anti-CD3 monoclonal antibodies. In addition, we demonstrated that more than 20% of B220+ cells obtained from normal mouse spleen expressed ACBMs.
Proceedings of the National Academy of Sciences of the United States of America © 1996 National Academy of Sciences